Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 113

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 113
---
 untrue due to a change in circumstance or otherwise, or the covenants and agreements of Aadi under the Divestiture Agreement are breached. Our stockholders are not third-party beneficiaries under the Divestiture Agreement and should not rely on the representations, warranties, covenants and agreements or any descriptions thereof as characterizations of the actual state of facts or condition of Aadi, Aadi Sub or Kaken or any of their respective affiliates or businesses. Moreover, information concerning the subject matter of the representations, warranties, covenants and agreements may change after the date of the Divestiture Agreement. Certain of the representations, warranties, covenants and agreements will survive the completion of the Divestiture, subject to certain time periods set forth in the Divestiture Agreement, and Aadi is subject to certain indemnification obligations with respect to such representations, warranties, covenants and agreements. In addition, you should not rely on the covenants and agreements in the Divestiture Agreement as actual limitations on the respective businesses of Aadi, Aadi Sub or Kaken because the parties may take certain actions that are either expressly permitted in the confidential disclosure letter to the Divestiture Agreement or as otherwise consented to by the appropriate party, which consent may be given without notice to the public (prior or otherwise). The Divestiture Agreement is described below, and included as Annex A, only to provide you with information regarding its terms and conditions, and not to provide you with any other factual information regarding Aadi, Aadi Sub, Kaken or their respective businesses. Accordingly, the representations, warranties, covenants and other agreements in the Divestiture Agreement should not be read alone, and you should read the information provided elsewhere in this document and in our filings with the SEC regarding Aadi, Aadi Sub and their respective businesses.

Closing and Effect of the Divestiture

The Divestiture Agreement provides that the completion of the Divestiture will take place (1) on a date to be agreed upon by Kaken and Aadi that is no
later than the second business day after the last condition to be satisfied or waived of the conditions to closing set forth in the Divestiture Agreement is satisfied or waived (excluding conditions that by their terms are to be satisfied as the
closing, but subject to the satisfaction or waiver of each of such conditions); or (2) at such other time agreed to in writing by Aadi and Kaken.

- 73 -

The Divestiture Agreement provides that